原标题：强生公司的疫苗被紧急停止使用，美国的抗流行“旗帜”会下降吗？ 对市场有什么影响？
概括
[Johnson&JohnsonVaccineswashaltedurgentlyWillthe”bigbanner”ofUSvaccinestocksfall?Whatistheimpactonthemarket?】ThecrisisofJohnson&JohnsonVaccinehasaffectedthetrendoftheglobalmarketovernightInvestorsarenotwithoutworryabouttheuncertaintyoftheepidemicpreventionandcontrolprospectscausedbythesuspensionofJohnson&JohnsonvaccineHoweverasofnowhealthexpertsandofficialsintheUnitedStateshaveemphasizedthatthesuspensionofJohnson&Johnson’svaccineisonlytoclarifythepathogenesisofthrombosisandthecorrespondingtreatmentplanIntermsofthemarkettheJohnson&JohnsonvaccineincidenthasmixedeffectsonthemarketAsofthecloseovernighttheUSStandard&Poor’s500IndexhitarecordhighduringtheintradayandclosingperiodbuttheDowfellandtheeconomicrestartconceptstocksweregenerallyunderpressure(Britishisfinancialsituation)
As more and more people are vaccinated, the side effects of the vaccine received by the Centers for Disease Control and Prevention in the United States are also increasing. There are three vaccines in the country (Pfizer, Moderna andJohnson), common side effects include muscle pain, redness, swelling, fatigue, headache, chills, fever, nausea and nausea.Among them, Moderna vaccine is compared withPfizerIt is easier for the vaccinators to experience symptoms of fatigue and headaches.andJohnsonThe side effects seem to be much more serious.
On Tuesday, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention jointly issued a statement recommending a suspensionJohnsonThe reason for the vaccination was that six women under the age of 50 (patients between the ages of 18-48) had rare blood clotting symptoms during the previous vaccination. One of them has died as a result, and the other one The situation is serious.
Before Johnson’s vaccination was suspended, the AstraZeneca vaccine, which was also an adenovirus vector virus, had caused many cases of adverse blood coagulation reactions of varying degrees. AstraZeneca’s vaccine has caused many deaths caused by unidentified blood clots. The vaccine has also been temporarily stopped in European countries, but most of it has now resumed.
Although Johnson & Johnson received approval from the United States in February and then received approval from Europe in March, the company has indicated that it will postpone the release of vaccines in Europe. A week ago, European regulators said they were evaluating rare blood clots in four vaccinators in the United States. South Africa has also suspended vaccines against Johnson & Johnson, and many countries have indicated that they are currently considering whether to suspend vaccines against Johnson & Johnson.
Johnson & Johnson’s stock price closed down 1.34% on Tuesday. The company said it was working closely with regulators and said it has not found a clear causal relationship between thrombosis and Johnson & Johnson’s vaccine. CDC may have further news to announce on Wednesday night Beijing time.
The crisis of Johnson & Johnson Vaccine has affected the trend of the global market overnight. Investors are not without worry about the uncertainty of the epidemic prevention and control prospects caused by the suspension of Johnson & Johnson Vaccine.
The market has always had high expectations for the single-dose vaccines of Johnson & Johnson and AstraZeneca. Due to their low-cost characteristics, these two vaccines have always been regarded as important weapons in the global fight against the epidemic. However, the current crisis may make some people who are skeptical of vaccines more suspicious. This will bring more uncertainty in the fight against the epidemic in the context of a surge in new crown cases in many states in the United States.
Dr. Steve Schrantz, an assistant professor of medicine at the University of Chicago and an expert in infectious disease research, said that this matter is difficult to say, and it may cause people to have further suspicions. Data show that since the beginning of April, the United States has stabilized from the original peak of 3 million doses of vaccines per day. By February 13, West Virginia is the state with the most vaccinations, but the state’s efficiency has declined. , Fell from 95% to 74%. At the same time, nearly ten states, including Arkansas, Georgia, and Mississippi, have slowed their recent vaccination rates.
However, as of now, health experts and officials in the United States have emphasized that the suspension of Johnson & Johnson vaccine is only to clarify the pathogenesis of thrombosis and the corresponding treatment plan.
Officials in the Biden administration emphasized that the suspension of vaccines against Johnson & Johnson will not affect the government’s subsequent vaccination goals. White House official Jeff Zients said in a latest statement,PfizerThe 25 million doses of vaccines produced by Moderna and Moderna are being distributed smoothly every week, and 28 million doses will be distributed this week. In addition, Pfizer also announced on Tuesday afternoon that it will increase vaccine production by 10% more than previously promised. This is enough to maintain a vaccination rate of 3 million doses per day and achieve the goal of 200 million doses of vaccine when Biden takes office for 100 days.
In comparison, there are currently about 6.8 million people in the United States vaccinated with Johnson & Johnson’s vaccine. In addition, about 9 million doses are still being sent to the states before the suspension.
Dr. Sarah Fortune, professor of immunology at the Harvard School of Public Health, said that even if the vaccine is related to blood clots, its benefits still far outweigh the risks of side effects. In previous experiments, Johnson & Johnson vaccine has shown 66.1% effectiveness in preventing moderate to severe new crown infections.
In addition, Dr. Jorge Moreno, assistant professor of medicine at Yale University School of Medicine, also believes that the suspension of Johnson & Johnson’s vaccination should not cause panic among the crowd, which just shows that the federal health authorities attach importance to safety issues.
SVB LeerinkAnalystIt is believed that the CDC may update its recommendation to not vaccinate women under the age of 50 with the vaccine. Johnson & Johnson vaccine will resume vaccination later.
Dr. Fauci, Health Advisor to the President of the United States, also said: “The suspension of Johnson & Johnson’s new crown vaccine seems to be a few days to a few weeks, rather than a few weeks to a few months. People who have recently received the Johnson & Johnson new crown vaccine should be aware of side effects, but the risk is very low.”
In terms of the market, the Johnson & Johnson vaccine incident has mixed effects on the market.
As of the close overnight, the US Standard & Poor’s 500 Index hit a record high during the intraday and closing period, but the Dow fell and the economic restart concept stocks were generally under pressure.
Mike Loewengart, managing director of ETRADE Financial’s investment strategy department, said on Tuesday: “Although (J&J news) may trigger some short-term fluctuations, investors are quite confident in the full recovery of the economy.”
Related reports:
U.S. regulators propose to suspend the use of Johnson & Johnson’s new crown vaccine
Johnson & Johnson’s new crown vaccine has been hit hard by Goldman Sachs and Xiao Mo
(Source: Yingwei Finance)
(Editor in charge: DF537)
Solemnly declare: The purpose of this information is to spread more information, and it has nothing to do with this stand.